These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1701170)

  • 41. Estimation of cholesterol loading of the low-density lipoprotein fraction in diabetic subjects without ultracentrifugation.
    Yoshino G; Iwai M; Matsuba K; Iwatani I; Matsushita M; Kazumi T; Baba S
    Diabetes Res Clin Pract; 1989 Aug; 7(2):155-7. PubMed ID: 2776655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein lipase association with lipoproteins involves protein-protein interaction with apolipoprotein B.
    Choi SY; Sivaram P; Walker DE; Curtiss LK; Gretch DG; Sturley SL; Attie AD; Deckelbaum RJ; Goldberg IJ
    J Biol Chem; 1995 Apr; 270(14):8081-6. PubMed ID: 7713910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.
    Goldberg IJ; Wagner WD; Pang L; Paka L; Curtiss LK; DeLozier JA; Shelness GS; Young CS; Pillarisetti S
    J Biol Chem; 1998 Dec; 273(52):35355-61. PubMed ID: 9857078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans.
    Reyes-Soffer G; Moon B; Hernandez-Ono A; Dionizovik-Dimanovski M; Jimenez J; Obunike J; Thomas T; Ngai C; Fontanez N; Donovan DS; Karmally W; Holleran S; Ramakrishnan R; Mittleman RS; Ginsberg HN
    Sci Transl Med; 2016 Jan; 8(323):323ra12. PubMed ID: 26819195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regional specificities of monoclonal anti-human apolipoprotein B antibodies.
    Krul ES; Kleinman Y; Kinoshita M; Pfleger B; Oida K; Law A; Scott J; Pease R; Schonfeld G
    J Lipid Res; 1988 Jul; 29(7):937-47. PubMed ID: 2457642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Limited proteolysis selectively destroys epitopes on apolipoprotein B in low density lipoproteins.
    Hahm KS; Tikkanen MJ; Dargar R; Cole TG; Davie JM; Schonfeld G
    J Lipid Res; 1983 Jul; 24(7):877-85. PubMed ID: 6195279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunochemical evidence that human apoB differs when expressed in rodent versus human cells.
    Wang X; Chauhan V; Nguyen AT; Schultz J; Davignon J; Young SG; Boren J; Innerarity TL; Rutai H; Milne RW
    J Lipid Res; 2003 Mar; 44(3):547-53. PubMed ID: 12562832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67/B-100 heterozygotes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Ordovas JM; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):881-8. PubMed ID: 9157951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased expression of a particular epitope on plasma apolipoprotein B of patients with coronary artery disease.
    Jeng JR; Shieh SM; Chiu HC
    Biochim Biophys Acta; 1993 Jun; 1181(3):287-94. PubMed ID: 7686401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.
    Weisgraber KH; Innerarity TL; Newhouse YM; Young SG; Arnold KS; Krauss RM; Vega GL; Grundy SM; Mahley RW
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9758-62. PubMed ID: 3200853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B.
    McNamara JR; Small DM; Li Z; Schaefer EJ
    J Lipid Res; 1996 Sep; 37(9):1924-35. PubMed ID: 8895058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients.
    Reade V; Tailleux A; Reade R; Harduin P; Cachera C; Tacquet A; Fruchart JC; Fievet C
    Kidney Int; 1993 Dec; 44(6):1360-5. PubMed ID: 7508006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rat monoclonal antibodies to rabbit and human serum low-density lipoprotein.
    Gherardi E; Hutchings A; Galfre G; Bowyer DE
    Biochem J; 1988 May; 252(1):237-45. PubMed ID: 2458711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoprotein B-100 Hopkins (arginine4019----tryptophan). A new apolipoprotein B-100 variant in a family with premature atherosclerosis and hyperapobetalipoproteinemia.
    Ladias JA; Kwiterovich PO; Smith HH; Miller M; Bachorik PS; Forte T; Lusis AJ; Antonarakis SE
    JAMA; 1989 Oct; 262(14):1980-8. PubMed ID: 2778934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
    Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
    J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary structure of apoB-100.
    Yang C; Gu ZW; Yang M; Gotto AM
    Chem Phys Lipids; 1994 Jan; 67-68():99-104. PubMed ID: 8187250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.